Literature DB >> 2460644

Mapping of antigenic domains of Sendai virus nucleocapsid protein expressed in Escherichia coli.

D S Gill1, S Takai, A Portner, D W Kingsbury.   

Abstract

Several nonoverlapping epitopes were mapped on the primary sequence of the Sendai virus NP protein. After a complete cDNA clone of the Sendai virus NP gene was expressed in Escherichia coli, deletion constructs were used to generate a series of overlapping NP fragments deleted at their C termini. Immunoblot analyses with 11 monoclonal antibodies identified four antigenic sites. All of these sites resided in the C-terminal half of NP and were also the only sites detected with a polyclonal serum. These findings confirm and extend the evidence that the C terminus of the NP protein represents the domain exposed on the surface of the nucleocapsid. One of the monoclonal antibodies reacted with a site, comprising only 6 amino acids, lying with a hinge between an alpha-helix and a beta-strand in the predicted secondary structure of NP. Since this antibody is a potent inhibitor of in vitro viral RNA synthesis (K. L. Deshpande and A. Portner, Virology 139:32-42, 1984), the epitope may be critical to the flexibility of the NP molecule that makes the RNA template accessible during RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460644      PMCID: PMC253604     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Use of the lambda phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles.

Authors:  H U Bernard; D R Helinski
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Mapping of monoclonal antibodies to the Sendai virus P protein and the location of its phosphates.

Authors:  S Vidal; J Curran; C Orvell; D Kolakofsky
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

3.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Sendai virus-induced transcriptase from infected cells: polypeptides in the transcriptive complex.

Authors:  H O Stone; D W Kingsbury; R W Darlington
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Structural and functional analysis of Sendai virus nucleocapsid protein NP with monoclonal antibodies.

Authors:  K L Deshpande; A Portner
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

8.  the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide.

Authors:  M H Heggeness; A Scheid; P W Choppin
Journal:  Virology       Date:  1981-10-30       Impact factor: 3.616

9.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

10.  Versatile expression vectors for high-level synthesis of cloned gene products in Escherichia coli.

Authors:  R Crowl; C Seamans; P Lomedico; S McAndrew
Journal:  Gene       Date:  1985       Impact factor: 3.688

View more
  9 in total

1.  Complete nucleotide sequence of a mumps virus genotype I strain isolated in Korea.

Authors:  Joo-Yeon Lee; Byoung-Kuk Na; Ho-Dong Lee; Sung-Wook Chang; Kyung-Ae Kim; Jee-Hee Kim; Hae-Wol Cho; Joon Kim; Chun Kang
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

2.  Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein.

Authors:  H E Homann; W Willenbrink; C J Buchholz; W J Neubert
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation.

Authors:  J Curran; H Homann; C Buchholz; S Rochat; W Neubert; D Kolakofsky
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

4.  Molecular evolution of human paramyxoviruses. Nucleotide sequence analyses of the human parainfluenza type 1 virus NP and M protein genes and construction of phylogenetic trees for all the human paramyxoviruses.

Authors:  K Miyahara; S Kitada; M Yoshimoto; H Matsumura; M Kawano; H Komada; M Tsurudome; S Kusagawa; M Nishio; Y Ito
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Conformational maturation of measles virus nucleocapsid protein.

Authors:  A F Gombart; A Hirano; T C Wong
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites.

Authors:  H Goto; N Minamoto; H Ito; T R Luo; M Sugiyama; T Kinjo; A Kawai
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Characterization of immunodominant linear B-cell epitopes on the carboxy terminus of the rinderpest virus nucleocapsid protein.

Authors:  Kang-Seuk Choi; Jin-Ju Nah; Young-Joon Ko; Shien-Young Kang; Kyoung-Jin Yoon; Yi-Seok Joo
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Nipah virus in Lyle's flying foxes, Cambodia.

Authors:  Jean-Marc Reynes; Dorian Counor; Sivuth Ong; Caroline Faure; Vansay Seng; Sophie Molia; Joe Walston; Marie Claude Georges-Courbot; Vincent Deubel; Jean-Louis Sarthou
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

Review 9.  Mapping of viral epitopes with prokaryotic expression products.

Authors:  J A Lenstra; J G Kusters; B A van der Zeijst
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.